The race to develop a coronavirus vaccine heated up on global stock markets on Thursday as shares in China’s CanSino Biologics surged on their first day of trading in Shanghai while Germany’s CureVac prepared to sell shares in New York.
开发新型冠状病毒疫苗的竞赛周四在manbetx app苹果 股市升温。manbetx3.0 康希诺生物(CanSino Biologics)股票在上海交易首日飙升，而德国的CureVac准备在纽约发行股票。
您已阅读7%（318字），剩余93%（4408字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。